Bernhardt G. Zeiher
Director · Entrada Therapeutics, Inc.
- 2026
- Jun 12, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Bernhardt G. Zeiher files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kush Parmar - $3.65M in TRDA purchases and sales in the last 12 months
- MPM BioVentures 2014, L.P. - $3.60M in TRDA purchases and sales in the last 12 months
- MPM BIOVENTURES 2018, L.P. - $3.60M in TRDA purchases and sales in the last 12 months
- Joshua B. Cohen - $3.60M in AMLX purchases and sales in the last 12 months
- Justin B. Klee - $3.59M in AMLX purchases and sales in the last 12 months
- 5AM Ventures V, L.P. - $3.00M in TRDA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Bernhardt G. Zeiher?
Bernhardt G. Zeiher is a corporate insider, tracked as Director of Entrada Therapeutics, Inc. (TRDA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Bernhardt G. Zeiher last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 4 filings going back to 2026.
Has Bernhardt G. Zeiher been buying or selling stock?
Recorded transactions: 1 open-market purchase ($29K) and 0 open-market sales across all tracked filings.
